Dr. Cross is a Reader in Cancer Epidemiology in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. She is also the Head of the Cancer Screening and Prevention Research Group (http://csprg.org.uk) in the Department of Surgery and Cancer at Imperial.
She completed her PhD at Cambridge University and then obtained a post-doctoral fellowship within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, United States. After two years of post-doctoral research, Dr. Cross was awarded a research fellowship and shortly after became a tenure-track investigator at NCI. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut. Dr. Cross received the NIH Fellows Award for Research Excellence, the DCEG Fellowship Achievement Award for Outstanding Accomplishments, the DCEG Award for Outstanding Research Paper by a Fellow, the NCI Mentor of Merit Award, and the NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.
Between 2005 and 2013, Dr. Cross was Principal Investigator of two colonoscopy screening studies (the Polyp Prevention Trial and the CONCeRN study), a metabolomics initiative within DCEG, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project. In 2013, Dr. Cross joined Imperial College to pursue her research interests in gastrointestinal malignancies and etiologic studies of lifestyle factors and cancer risk. She currently leads the Cancer Prevention and Early Detection theme in the Cancer Research UK centre at Imperial. In addition to her research commitments, she is co-Director of the MSc in Epidemiology at Imperial College.
et al., 2019, Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition, International Journal of Cancer, Vol:144, ISSN:0020-7136, Pages:240-250
et al., 2019, Discovery of common and rare genetic risk variants for colorectal cancer, Nature Genetics, Vol:51, ISSN:1061-4036, Pages:76-+
et al., 2018, Gallstones and incident colorectal cancer in a large pan-European cohort study., Int J Cancer
et al., 2018, Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study., Br J Cancer
et al., 2018, Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study., Gut